The FDA has approved a drug developed by Cytokinetics for its intended use as a treatment.
Steady: 0 in the last 7 days
Updated sep 23
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA has approved a drug developed by Cytokinetics for its intended use as a treatment.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Product Myqorzo received FDA approval.Sub-event
Cytokinetics drug moves toward global commercial rollout following regulatory approvals.1 source
FDA approves Cytokinetics' drug as a treatment.1 source
Keep exploring
The entities involved
- FDA
-
Cytokinetics
company in South San Francisco, United States
Related events
- Arise is seeking FDA approval for a drug as of October 7, 2026.
- FDA approval expands patient access to therapies for ACCORD.
- Research advances have led to the approval of new therapies by the FDA.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.